Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.
about
Regulation of mycolactone, the Mycobacterium ulcerans toxin, depends on nutrient sourceAnalysis of the vaccine potential of plasmid DNA encoding nine mycolactone polyketide synthase domains in Mycobacterium ulcerans infected miceProteomic analysis of the action of the Mycobacterium ulcerans toxin mycolactone: targeting host cells cytoskeleton and collagen.Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad modelEffectiveness of routine BCG vaccination on buruli ulcer disease: a case-control study in the Democratic Republic of Congo, Ghana and Togo.Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease.Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer.Spontaneous Healing of Mycobacterium ulcerans Lesions in the Guinea Pig ModelVaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer.Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice.Overexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine EfficacyAn Optimized Method for Extracting Bacterial RNA from Mouse Skin Tissue Colonized by Mycobacterium ulceransHistory, biology and chemistry of Mycobacterium ulcerans infections (Buruli ulcer disease).
P2860
Q28535119-809BACA4-BAD0-483A-AE80-F968FC78B761Q28538249-4ADF9887-2937-4AAD-9523-B705E74E76F0Q34016179-859D7E8E-9D60-498E-A708-F8F5AB335DE4Q34702499-00AA75C0-EC60-44E3-9BEF-3291EB75D9DEQ34875651-A760D962-1F86-48C5-A963-30D59F04D88AQ35746584-549B2B00-3598-4DB1-B2EC-960706FEE54FQ35782951-7ED89669-353E-46D1-BCB5-638D2448FDF1Q35857386-CE358DEE-F19F-46FA-BE24-572BE12112E7Q35915755-C5E67058-6374-458E-91BD-832BA90ED95CQ35919532-5289B806-9D32-4277-AAD8-3E83E4611AE9Q36219941-2B571FAB-5C55-4272-9AED-3B7F809D82EAQ37719029-1C62E3F1-251B-45C9-A789-CEB99A3809B1Q38157768-C0EAB0EC-F9B5-4DAD-8D6A-F17FC51C4593
P2860
Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Cellular immunity confers tran ...... acterium ulcerans vaccination.
@ast
Cellular immunity confers tran ...... acterium ulcerans vaccination.
@en
Cellular immunity confers tran ...... acterium ulcerans vaccination.
@nl
type
label
Cellular immunity confers tran ...... acterium ulcerans vaccination.
@ast
Cellular immunity confers tran ...... acterium ulcerans vaccination.
@en
Cellular immunity confers tran ...... acterium ulcerans vaccination.
@nl
prefLabel
Cellular immunity confers tran ...... acterium ulcerans vaccination.
@ast
Cellular immunity confers tran ...... acterium ulcerans vaccination.
@en
Cellular immunity confers tran ...... acterium ulcerans vaccination.
@nl
P2093
P2860
P50
P1433
P1476
Cellular immunity confers tran ...... acterium ulcerans vaccination.
@en
P2093
Françoise Portaels
Manuel T Silva
Teresa G Martins
P2860
P304
P356
10.1371/JOURNAL.PONE.0033406
P407
P577
2012-03-08T00:00:00Z